April 14, 2023
Now available ALTUVIIIO™
ALTUVIIIO™ [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is a recombinant DNA-derived, Factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for:
- Routine prophylaxis to reduce the frequency of bleeding episodes
- On-demand treatment & control of bleeding episodes
- Perioperative management of bleeding
Limitation of Use:
ALTUVIIIO is not indicated for the treatment of von Willebrand disease.
Please see full prescribing information here.